R1 RCM Inc logo

R1 RCM Inc (RCM)

Market Closed
18 Nov, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
14. 31
0
0%
$
6.04B Market Cap
- P/E Ratio
- Div Yield
0 Volume
0.02 Eps
$ 14.31
Previous Close
Add Transaction
Day Range
14.31 14.31
Year Range
14.31 14.31
Want to track RCM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RCM closed Monday higher at $14.31, an increase of 0% from Friday's close, completing a monthly increase of 0% or $14.31. Over the past 12 months, RCM stock gained 0%.
RCM is not paying dividends to its shareholders.
The last earnings report, released on May 06, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0117%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

RCM Chart

People also search for

Chime Financial, Inc. – Class A Common Stock
$ 31.73
+2.8525%
AGNC Investment Corp. 6.125% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
$ 25.19
-0.2179%
AGNC Investment Corp. 7.75% Series B Cumulative Redeemable Preferred Stock
$ 25.24
+0.0396%
American Funds Conservative Growth and Income Portfolio - Class F-1
$ 14.92
0%
T. Rowe Price Intl Bd (USD Hdgd)
$ 8.47
-0.1179%
Here's What Key Metrics Tell Us About R1 RCM INC (RCM) Q3 Earnings

Here's What Key Metrics Tell Us About R1 RCM INC (RCM) Q3 Earnings

Although the revenue and EPS for R1 RCM INC (RCM) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 year ago
R1 RCM Inc. (RCM) Reports Q3 Loss, Tops Revenue Estimates

R1 RCM Inc. (RCM) Reports Q3 Loss, Tops Revenue Estimates

R1 RCM Inc. (RCM) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to break-even earnings per share a year ago.

Zacks | 1 year ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into R1 Rcm Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into R1 Rcm Inc.

NEW YORK, NY / ACCESSWIRE / October 31, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.

Accesswire | 1 year ago

R1 RCM Inc (RCM) FAQ

What is the stock price today?

The current price is $14.31.

On which exchange is it traded?

R1 RCM Inc is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is RCM.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 6.04B.

Has R1 RCM Inc ever had a stock split?

No, there has never been a stock split.

R1 RCM Inc Profile

Insurance Industry
Financials Sector
Lee Rivas CEO
NASDAQ (NGS) Exchange
77634L105 CUSIP
US Country
29,400 Employees
- Last Dividend
22 Jun 2022 Last Split
20 May 2010 IPO Date

Overview

R1 RCM Inc. specializes in providing comprehensive technology-driven solutions designed to enhance the financial performance and patient experience within health systems, hospitals, and physician groups. With a focus on creating an operating partnership through end-to-end solutions, R1 RCM Inc. aims at improving the financial leverage and revenue of its healthcare clientele. Established in 2003 and based in Murray, Utah, the company stands out for its wide-ranging modular solutions tailored to meeting the specific revenue cycle management needs of its customers, ensuring a significant impact on their financial health and regulatory compliance.

Products and Services

  • Functional Partnership: An outsourcing solution aimdataed at achieving improvements across specific areas of the revenue cycle for hospitals and physician group customers. This encompasses the fine-tuning of operations to enhance efficiency and profitability.
  • Revenue Recovery: This service accelerates the collection of cash from payers and patients, focusing on resolving outstanding receivables more quickly and effectively. It is essential for healthcare providers looking to improve their cash flow and operational bottom line.
  • Revenue Optimization: A strategic solution designed to uncover and reclaim missed or underreported revenue opportunities. By identifying areas of lost revenue, this service helps healthcare institutions maximize their earning potential for the services they provide.
  • Clinical Integrity: This solution focuses on enhancing the accuracy of documentation and coding, ensuring healthcare providers are fully compensated for the procedures and services rendered. Improving clinical integrity is key to maximizing earned revenue and mitigating compliance risks.
  • Regulatory Navigation: Aimed at ensuring compliance with government reimbursement regulations, this service also includes strategies for pharmacy savings. It prioritizes a compliance-first approach to help healthcare organizations navigate the complex landscape of healthcare regulations while securing accurate reimbursement and achieving cost savings.

Contact Information

Address: 434 W. Ascension Way
Phone: 312 324 7820